A prospective controlled multicentre study of clarithromycin in pregnancy

Keyphrases

• Clarithromycin 100%
• Pregnant Women 75%
• Major Malformations 50%
• First Trimester 25%
• No Significant Difference 25%
• Baseline Risk 25%
• Antibiotics 25%
• Counseling 25%
• Safety in Pregnancy 25%
• Spontaneous Preterm Birth (sPTB) 25%
• Human Data 25%
• Prospective Controlled Study 25%
• Evidence-based 25%
• Skin Tissue 25%
• Alcohol Use 25%
• Indications for Use 25%
• Minor Malformations 25%
• Soft Tissue Infection 25%
• Erythromycin 25%
• Cleft Palate 25%
• Macrolide Antibiotics 25%
• Cardiovascular Anomalies 25%
• Upper Respiratory Tract 25%
• Uncontrolled Study 25%
• Data-limited 25%
• Action Spectrum 25%
• Lower Respiratory 25%
• Spontaneous Abortion Rate 25%
• Embryo Loss 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Clarithromycin 100%
• Congenital Malformation 50%
• Spontaneous Abortion 50%
• Ethanol 25%
• Antibiotics 25%
• Macrolide 25%
• Soft Tissue Infection 25%
• Cardiovascular Malformation 25%
• Erythromycin 25%
• Cleft Palate 25%

Biochemistry, Genetics and Molecular Biology

• First Trimester Pregnancy 100%
• Macrolide 100%
• Action Spectrum 100%